Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Tri-Committee Proposal Would Take 14 Years To Close Part D Donut Hole, Study Says

This article was originally published in The Pink Sheet Daily

Executive Summary

An analysis by Avalere Health of the proposal to eliminate the coverage gap in the current Part D benefit says formula changes would need until 2023 to take full effect.

You may also be interested in...



Part D Rebates Can Pay For Filling In Donut Hole, CBO Says

Rebates for Medicare/Medicaid dual eligible enrollees would generate $63 billion over 10 years, Congressional Budget Office estimates; phase-out of donut hole would cost only $47 billion, but most expensive years come after 10 year budget window.

Part D Rebates Can Pay For Filling In Donut Hole, CBO Says

Rebates for Medicare/Medicaid dual eligible enrollees would generate $63 billion over 10 years, Congressional Budget Office estimates; phase-out of donut hole would cost only $47 billion, but most expensive years come after 10 year budget window.

Dollars For Donuts: PhRMA's $80 Bil. Coup In Health Care Reform

PhRMA's commitment to contribute $80 billion toward health systems savings over the next 10 years looks like an important tactical win for the brand name industry entering the critical phase of the health reform debate

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel